Kazuhiro Nouso

9.2k total citations
221 papers, 5.0k citations indexed

About

Kazuhiro Nouso is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Kazuhiro Nouso has authored 221 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 129 papers in Hepatology, 108 papers in Epidemiology and 47 papers in Molecular Biology. Recurrent topics in Kazuhiro Nouso's work include Liver Disease Diagnosis and Treatment (90 papers), Hepatocellular Carcinoma Treatment and Prognosis (84 papers) and Hepatitis C virus research (36 papers). Kazuhiro Nouso is often cited by papers focused on Liver Disease Diagnosis and Treatment (90 papers), Hepatocellular Carcinoma Treatment and Prognosis (84 papers) and Hepatitis C virus research (36 papers). Kazuhiro Nouso collaborates with scholars based in Japan, United States and United Kingdom. Kazuhiro Nouso's co-authors include Kazuhide Yamamoto, Shinichiro Nakamura, Toshihiro Higashi, Hidenori Shiraha, Akinobu Takaki, Yoshitaka Takuma, Yoshiyuki Kobayashi, Yasuhiro Miyake, Kazuya Kariyama and Harushige Nakatsukasa and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Kazuhiro Nouso

210 papers receiving 4.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kazuhiro Nouso Japan 39 2.5k 1.9k 1.3k 1.1k 1.1k 221 5.0k
Wolfgang Sieghart Austria 35 2.6k 1.0× 1.8k 0.9× 1.2k 0.9× 767 0.7× 999 0.9× 87 4.7k
Hirohisa Okabe Japan 37 1.8k 0.7× 1.2k 0.6× 1.2k 0.9× 838 0.7× 1.7k 1.5× 253 4.8k
Thomas Decaens France 31 2.3k 0.9× 1.3k 0.7× 1.1k 0.9× 591 0.5× 720 0.7× 141 3.9k
Jean‐Frédéric Blanc France 41 2.9k 1.1× 1.8k 0.9× 1.8k 1.4× 1.4k 1.3× 2.0k 1.8× 164 6.8k
Matthias Pinter Austria 37 2.9k 1.2× 2.1k 1.1× 714 0.5× 646 0.6× 1.1k 1.0× 156 4.7k
Helen L. Reeves United Kingdom 36 4.0k 1.6× 4.6k 2.4× 2.2k 1.7× 1.3k 1.2× 1.3k 1.2× 95 8.3k
Si Hyun Bae South Korea 40 3.9k 1.5× 2.7k 1.4× 759 0.6× 672 0.6× 818 0.7× 250 5.6k
Tohru Utsunomiya Japan 37 1.3k 0.5× 880 0.5× 1.5k 1.1× 839 0.7× 1.7k 1.6× 166 4.3k
Hitoshi Kohno Japan 40 1.9k 0.8× 1.0k 0.5× 1.2k 0.9× 802 0.7× 740 0.7× 135 5.2k
Boheng Zhang China 33 2.2k 0.9× 1.6k 0.8× 982 0.8× 1.0k 0.9× 1.1k 1.0× 83 4.1k

Countries citing papers authored by Kazuhiro Nouso

Since Specialization
Citations

This map shows the geographic impact of Kazuhiro Nouso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuhiro Nouso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuhiro Nouso more than expected).

Fields of papers citing papers by Kazuhiro Nouso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazuhiro Nouso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuhiro Nouso. The network helps show where Kazuhiro Nouso may publish in the future.

Co-authorship network of co-authors of Kazuhiro Nouso

This figure shows the co-authorship network connecting the top 25 collaborators of Kazuhiro Nouso. A scholar is included among the top collaborators of Kazuhiro Nouso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuhiro Nouso. Kazuhiro Nouso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hatanaka, Takeshi, Satoru Kakizaki, Atsushi Hiraoka, et al.. (2025). Comparison of Surgical Resection and Radiofrequency Ablation for Early‐Stage HCC Patients With Child–Pugh Class B. Journal of Gastroenterology and Hepatology. 40(8). 2068–2077.
2.
So, Ryuhei, Kazuya Kariyama, Shunsuke Oyamada, et al.. (2025). Effectiveness of screening and ultra-brief intervention for hazardous drinking in primary care: pragmatic cluster randomised controlled trial. BMJ. 390. e083985–e083985.
3.
So, Ryuhei, Kazuya Kariyama, Takahiro Yamagishi, et al.. (2024). A smartphone app-based intervention combined with face-to-face sessions for alcohol dependence at internal medicine clinics: A randomized controlled trial. General Hospital Psychiatry. 90. 68–75. 3 indexed citations
4.
Tsuge, Mitsuru, Eiki Ichihara, Kou Hasegawa, et al.. (2024). Increased Oxidative Stress and Decreased Citrulline in Blood Associated with Severe Novel Coronavirus Pneumonia in Adult Patients. International Journal of Molecular Sciences. 25(15). 8370–8370. 1 indexed citations
5.
Ichihara, Eiki, Kou Hasegawa, Kenichiro Kudo, et al.. (2023). A randomized controlled trial of teprenone in terms of preventing worsening of COVID-19 infection. PLoS ONE. 18(10). e0287501–e0287501. 1 indexed citations
6.
Takeuchi, Yasuto, Kazuhiro Nouso, Shinichi Fujioka, et al.. (2023). The prediction of early progressive disease in patients with hepatocellular carcinoma receiving atezolizumab plus bevacizumab. Cancer Medicine. 12(17). 17559–17568. 3 indexed citations
7.
Kariyama, Kazuya, Kazuhiro Nouso, Atsushi Hiraoka, et al.. (2023). Treatment options for solitary hepatocellular carcinoma ≤5 cm: surgery vs. ablation: a multicenter retrospective study. SHILAP Revista de lepidopterología. 24(1). 71–80. 1 indexed citations
8.
Kumada, Takashi, Hidenori Toyoda, Satoshi Yasuda, et al.. (2022). Factors linked to hepatocellular carcinoma development beyond 10 years after viral eradication in patients with hepatitis C virus. Journal of Viral Hepatitis. 29(10). 919–929. 8 indexed citations
9.
Kudo, Masatoshi, Masafumi Ikeda, Kazuomi Ueshima, et al.. (2022). Response Evaluation Criteria in Cancer of the liver version 6 (Response Evaluation Criteria in Cancer of the Liver 2021 revised version). Hepatology Research. 52(4). 329–336. 12 indexed citations
10.
Kariyama, Kazuya, Kazuhiro Nouso, Atsushi Hiraoka, et al.. (2020). EZ-ALBI Score for Predicting Hepatocellular Carcinoma Prognosis. Liver Cancer. 9(6). 734–743. 36 indexed citations
11.
Kariyama, Kazuya, Kazuhiro Nouso, Hidenori Toyoda, et al.. (2019). Utility of FIB4-T as a Prognostic Factor for Hepatocellular Carcinoma. Cancers. 11(2). 203–203. 7 indexed citations
12.
Kariyama, Kazuya, Kazuhiro Nouso, Hidenori Toyoda, et al.. (2019). Treatment of Intermediate-Stage Hepatocellular Carcinoma in Japan: Position of Curative Therapies. Liver Cancer. 9(1). 41–49. 31 indexed citations
13.
Hiraoka, Atsushi, Takashi Kumada, Kunihiko Tsuji, et al.. (2018). Validation of Modified ALBI Grade for More Detailed Assessment of Hepatic Function in Hepatocellular Carcinoma Patients: A Multicenter Analysis. Liver Cancer. 8(2). 121–129. 149 indexed citations
14.
Hiraoka, Atsushi, Takashi Kumada, Kazuya Kariyama, et al.. (2018). Therapeutic potential of lenvatinib for unresectable hepatocellular carcinoma in clinical practice: Multicenter analysis. Hepatology Research. 49(1). 111–117. 57 indexed citations
15.
Nouso, Kazuhiro, Kazuya Kariyama, Yasuto Takeuchi, et al.. (2018). Simple screening method for the diagnosis of nonB-nonC hepatocellular carcinoma. Hepatoma Research. 2018. 2 indexed citations
16.
Hiraoka, Atsushi, Takashi Kumada, Masashi Hirooka, et al.. (2017). A better method for assessment of hepatic function in hepatocellular carcinoma patients treated with radiofrequency ablation: Usefulness of albumin–bilirubin grade. Hepatology Research. 48(3). E61–E67. 17 indexed citations
17.
Hiraoka, Atsushi, Takashi Kumada, Kazuhiro Nouso, et al.. (2016). Proposed New Sub-Grouping for Intermediate-Stage Hepatocellular Carcinoma Using Albumin-Bilirubin Grade. Oncology. 91(3). 153–161. 34 indexed citations
18.
Kinugasa, Hideaki, Kazuhiro Nouso, Takehiro Tanaka, et al.. (2015). Droplet digital PCR measurement of HER2 in patients with gastric cancer. British Journal of Cancer. 112(10). 1652–1655. 69 indexed citations
19.
Takuma, Yoshitaka, Kazuhiro Nouso, Yasuhiro Makino, Miho Hayashi, & Hiroshi Takahashi. (2010). Clinical trial: oral zinc in hepatic encephalopathy. Alimentary Pharmacology & Therapeutics. 32(9). 1080–1090. 95 indexed citations
20.
Tanaka, Hironori, Kazuhiro Nouso, Haruhiko Kobashi, et al.. (2006). Surveillance of hepatocellular carcinoma in patients with hepatitis C virus infection may improve patient survival. Liver International. 26(5). 543–551. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wolfgang Sieghart Breakdown of academic impact, for papers by Hirohisa Okabe Breakdown of academic impact, for papers by Thomas Decaens Breakdown of academic impact, for papers by Jean‐Frédéric Blanc Breakdown of academic impact, for papers by Matthias Pinter Breakdown of academic impact, for papers by Helen L. Reeves Breakdown of academic impact, for papers by Si Hyun Bae Breakdown of academic impact, for papers by Tohru Utsunomiya Breakdown of academic impact, for papers by Hitoshi Kohno Breakdown of academic impact, for papers by Boheng Zhang
Rankless by CCL
2026